Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart G Beattie

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transferEduardo Salido, Marisol Rodriguez-Pena, Alfredo Santana, et al.
The Journal of Gene Medicine|August 23, 2008
Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient miceStuart G Beattie, Eric Goetzman, Qiuishi Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophyRahul N Kanadia, Jihae Shin, Yuan Yuan, et al.
Human Gene Therapy|May 27, 2008
Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCADStuart G Beattie, Eric Goetzman, Thomas Conlon, et al.
The Journal of Gene Medicine|May 12, 2009
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiencyStefan F C Vaessen, Robert Jan Veldman, Elisabeth M Comijn, et al.
Nature Medicine|June 18, 2013
A largely random AAV integration profile after LPLD gene therapyChristine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 27, 2007
In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNAPedro E Cruz, Christian Mueller, Travis L Cossette, et al.
Journal of Translational Medicine|June 19, 2012
Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primatesCarmen Unzu, Sandra Hervás-Stubbs, Ana Sampedro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancerLucia Vanrell, Marianna Di Scala, Laura Blanco, et al.
Human Gene Therapy|February 16, 2011
Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primatesAstrid Pañeda, Maria Collantes, Stuart G Beattie, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transferEduardo Salido, Marisol Rodriguez-Pena, Alfredo Santana, et al.
The Journal of Gene Medicine|August 23, 2008
Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient miceStuart G Beattie, Eric Goetzman, Qiuishi Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophyRahul N Kanadia, Jihae Shin, Yuan Yuan, et al.
Human Gene Therapy|May 27, 2008
Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCADStuart G Beattie, Eric Goetzman, Thomas Conlon, et al.
The Journal of Gene Medicine|May 12, 2009
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiencyStefan F C Vaessen, Robert Jan Veldman, Elisabeth M Comijn, et al.
Nature Medicine|June 18, 2013
A largely random AAV integration profile after LPLD gene therapyChristine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 27, 2007
In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNAPedro E Cruz, Christian Mueller, Travis L Cossette, et al.
Journal of Translational Medicine|June 19, 2012
Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primatesCarmen Unzu, Sandra Hervás-Stubbs, Ana Sampedro, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancerLucia Vanrell, Marianna Di Scala, Laura Blanco, et al.
Human Gene Therapy|February 16, 2011
Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primatesAstrid Pañeda, Maria Collantes, Stuart G Beattie, et al.
Pageof 2